[Webinar] To Label or Not to Label? Understanding the Proposed Changes to the CODEX Standard for Allergen Labelling
In this webinar, allergen management expert Ben Remington speaks with Romer Labs product manager Martin Candia about the effects that proposed changes to the CODEX standard for allergen labelling may have. You will learn about potential changes that can bring about new regulations worldwide and other relevant issues, including:
- An updated list of global priority food allergens based on prevalence, potency and severity of allergic reaction
- Potentially new food allergens
- Thresholds of allergen content in final products
- The potential future of precautionary allergen labelling (PAL)
Watch the webinar
Useful links discussed in webinar
Ad hoc Joint FAO/WHO Expert Consultation on Risk Assessment of Food Allergens
- Part 1: Review and validation of Codex priority allergen list through risk assessment
- More info on Part 1 (full report), virtual meeting, 30 November – 11 December 2020, 28 January 2021, 8 February 2021
- Part 2: Review and establish threshold levels in foods of the priority allergens
- More info on Part 2 (summary and conclusions), virtual meeting, 15 March – 2 April 2021, 15 March 2022
- Part 3: Review and establish precautionary labelling in foods of the priority allergens
- More info on Part 3 (summary and conclusions), Virtual meeting, 18-29 October, 3 November 2021
Supporting information for hazard characterization and potency:
- Patel et al., 2021. https://doi.org/10.1016/j.jaci.2021.01.025
- Using data from food challenges to inform management of food-allergic consumers: a systematic review with individual participant data meta-analysis
- Turner et al., 2021. https://doi.org/10.1016/j.jaip.2021.08.008
- Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis
- Houben et al., 2020. https://doi.org/10.1016/j.fct.2020.111831
- Full range of population Eliciting Dose values for 14 priority allergenic foods and recommendations for use in risk characterization
ILSI Europe Practical Guidance on the Application of Food Allergen Quantitative Risk Assessment (QRA):
https://ilsi.eu/publication/practical-guidance-on-the-application-of-food-allergen-quantitative-risk-assessment-qra
Meet the speakers
Benjamin Remington, Ph.D.
Allergen Risk Analysis Consultant, Remington Consulting Group B.V.
An expert in thresholds and risk assessment for food allergens, Dr. Ben Remington is active in both clinical and food business operator settings. Currently, he applies his knowledge in dual roles as Adjunct Assistant Professor at the Food Allergy Research and Resource Program at the University of Nebraska and as a research and risk assessment consultant for the Remington Consulting Group B.V., based in the Netherlands. Ben serves as an Invited Member on the VITAL® Scientific Expert Panel, in addition to several other roles in organizations devoted to allergen risk assessment, novel methodologies and clinical immunology.
Ben serves as an invited member in several international organizations devoted to allergen risk assessment and risk management. Among others, highlights include:
- Member of the Food and Agriculture Organization of the United Nations (FAO) and World Health Organization (WHO) Ad hoc Joint FAO/WHO Expert Consultation on Risk Assessment of Food Allergens
- The Chair of the ILSI Europe Expert Group on Food Allergen Quantitative Risk Assessment
- Member of the VITAL® Scientific Expert Panel
- Member of the European Academy of Allergy and Clinical Immunology (EAACI) Food Allergen Task Force
Martin Candia, MSc
Product Manager at Romer Labs
Martin Candia has joined Romer Labs in November 2018 as product manager for the Allergens division and is involved in method validation and application support in allergen testing. He provides scientific and technical advice to sales staff worldwide and conducts workshops and webinars for customers.
He has extensive experience in the allergy field and has participated in projects aimed at developing both prophylactic and therapeutic treatments for allergies in children and adults. In the past, he has particularly focused his research on cow’s milk allergy and on the modulation of the allergic response by the use of peptides.
